<DOC>
	<DOCNO>NCT00190450</DOCNO>
	<brief_summary>The aim study show existence clinical benefit rise substitution striatal neuron degenerate among patient reach disease Huntington homologous neuron come human foetus , comparison treat group reference group not-treaty . The principal criterion progression motor score UHDRS compare value obtain group treat bilateral graft intrastriatal foetal neuron value obtain group control . At end protocol , patient control graft ( thus 18 month time compare treated group ) . A secondary evaluation envisage 18 month graft group control whole patient ( either 52 month ) . We able thus compare pre performance 18 month post-graft 60 patient .</brief_summary>
	<brief_title>MIG-HD : Multicentric Intracerebral Grafting Huntington 's Disease</brief_title>
	<detailed_description>The aim study show existence clinical benefit rise substitution striatal neuron degenerate among large cohort Huntington 's patient early stage homologous neuron come human foetus , This effect estimate , compare group patient treat first , result motor scale Unified Huntington Disease Rating Scale ( UHDRS , Huntington study group , 1996 ) . Transplants realize two surgical time avoid risk hurt per-operating , BI-CAUDES , transplant realize single time . The minimal interval transplant 2 week , let patient recover first general anaesthesia It 's multicentric study phase II randomise control , direct individual benefit .</detailed_description>
	<mesh_term>Huntington Disease</mesh_term>
	<criteria>Disease clinically declare since least 1 year , UHDRS motor &gt; =5 TFC &gt; = 10 . CAG &gt; = 36 Age 18 65 Family socially integrate subject Informed consent . Severe intellectual deterioration neuropsychiatric disorder make followup longitudinal complicate ( score MATTIS &lt; 120 ) . Notobservance appointment symptomatic treatment presurgical period . Intercurrent disease make surgical operation impossible . Associated disease neurological repercussion , intercurrent cerebral lesion IRM . Visceral affection engraves , evolutionary , bring play vital forecast make risk general anaesthesia . Mental Affection likely disturb adhesion protocol , particular antecedent hallucination spontaneous and/or induce drug ; antecedent serious depression require repeated hospitalization ; antecedent repeat suicide attempt . Cerebral morphological anomaly , others characteristic disease , note IRM tomodensitometry . Participation progress , stop since less three month , therapeutic protocol Huntington 's disease Exclusion Criteria ( prerandomization ) TFC &lt; 8 Notobservance appointment symptomatic treatment presurgical period . Intercurrent disease return surgery impossible immunosuppression . v Subject completely isolate family socially.. UHDRS motor &lt; 5 . Positives serology HIV1 , HIV2 , AgP24 , HTLV1 et 2 , HEPATITE B , HEPATITE C , syphilis Psychiatric disorder able compromise followup . Signs Huntington IRM .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Huntington</keyword>
	<keyword>graft</keyword>
	<keyword>cellular therapy</keyword>
	<keyword>striatum</keyword>
</DOC>